Healthcare Services company Dr. Lal Pathlabs announced Q2FY24 results: 1. Financial Performance - Total revenue of Rs 601 crore in Q2FY24, an increase of 12.6% compared to Q2FY23. - Revenue excluding RTPCR increased by 14.4% in Q2FY24. - EBITDA margin for Q2FY24 was 29.6%. - PBT for Q2FY24 was Rs 152 crore. - PAT for Q2FY24 was Rs 111 crore. - PAT margin for Q2FY24 was 18.4%. - The company's EPS for Q2FY24 was 13.2. 2. Operating Expenditure - Operating Expenditure for Q2FY24 was Rs 424 crore. - Operating Expenditure increased by 8.6% compared to Q2FY23. 3. Other Financial Highlights - Other Income for Q2FY24 was Rs 18 crore. - Depreciation cost for Q2FY24 was Rs 36 crore. - Finance cost for Q2FY24 was Rs 8 crore. Result PDF